Molecular Partners (MOLN) Short Interest Ratio & Short Volume $3.80 +0.09 (+2.43%) As of 07/2/2025 03:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Molecular Partners Short Interest DataMolecular Partners (MOLN) has a short interest of 35,600 shares, representing 0.10% of the float (the number of shares available for trading by the public). This marks a -10.55% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.5, indicating that it would take 3.5 days of the average trading volume of 14,792 shares to cover all short positions.Current Short Interest35,600 sharesPrevious Short Interest39,800 sharesChange Vs. Previous Month-10.55%Dollar Volume Sold Short$137.81 thousandShort Interest Ratio3.5 Days to CoverLast Record DateJune 15, 2025Outstanding Shares40,380,000 sharesFloat Size36,770,000 sharesShort Percent of Float0.10%Today's Trading Volume638 sharesAverage Trading Volume14,792 sharesToday's Volume Vs. Average4% Short Selling Molecular Partners? Sign up to receive the latest short interest report for Molecular Partners and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMOLN Short Interest Over TimeMOLN Days to Cover Over TimeMOLN Percentage of Float Shorted Over Time Molecular Partners Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202535,600 shares $137.81 thousand -10.6%0.1%3.5 $3.87 5/31/202539,800 shares $155.38 thousand -13.9%0.1%3.8 $3.90 5/15/202546,200 shares $177.45 thousand -9.8%0.1%4.4 $3.84 4/30/202551,200 shares $199.68 thousand +33.0%0.1%5 $3.90 4/15/202538,500 shares $144.57 thousand -1.8%0.1%5.5 $3.76 3/31/202539,200 shares $160.52 thousand -3.0%0.1%9.8 $4.10 3/15/202540,400 shares $175.34 thousand -6.3%0.1%10.1 $4.34 2/28/202543,100 shares $216.79 thousand +1.2%0.1%5.3 $5.03 2/15/202542,600 shares $209.59 thousand -8.2%0.1%3.9 $4.92 1/31/202546,400 shares $247.73 thousand +3.6%0.1%3.5 $5.34 Get the Latest News and Ratings for MOLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. 1/15/202544,800 shares $258.94 thousand -10.4%0.1%2.6 $5.78 12/31/202450,000 shares $237.50 thousand +2.5%0.1%2.1 $4.75 12/15/202448,800 shares $264.98 thousand -10.8%0.1%2 $5.43 11/30/202454,700 shares $318.35 thousand -5.7%0.2%2.3 $5.82 11/15/202458,000 shares $309.14 thousand +1.6%N/A3.2 $5.33 10/31/202457,100 shares $310.62 thousand +70.5%N/A3.5 $5.44 10/15/202433,500 shares $165.83 thousand +7.4%N/A1.4 $4.95 9/30/202431,200 shares $158.72 thousand +4.4%N/A1.9 $5.09 9/15/202429,900 shares $156.08 thousand +0.3%N/A1.7 $5.22 8/31/202429,800 shares $169.26 thousand -8.9%N/A0.8 $5.68 8/15/202432,700 shares $206.89 thousand -53.2%N/A0.9 $6.33 7/31/202469,900 shares $629.10 thousand +6.2%N/A1.9 $9.00 7/15/202465,800 shares $413.88 thousand -23.8%N/A2.4 $6.29 6/30/202486,300 shares $623.95 thousand -25.1%N/A3.2 $7.23 6/15/2024115,200 shares $779.90 thousand +134.2%N/A4.6 $6.77 5/31/202449,200 shares $177.12 thousand No ChangeN/A7.5 $3.60 5/15/202449,200 shares $182.53 thousand -8.0%N/A13.7 $3.71 4/30/202453,500 shares $202.28 thousand -5.1%N/A15.7 $3.78 4/15/202456,400 shares $222.78 thousand +17.8%N/A18.8 $3.95 3/31/202447,900 shares $201.18 thousand -2.2%N/A9.8 $4.20 3/15/202449,000 shares $194.04 thousand -12.5%N/A3.7 $3.96 2/29/202456,000 shares $240.80 thousand -7.6%N/A4.1 $4.30 2/15/202460,600 shares $282.09 thousand +3.6%N/A4.5 $4.66 1/31/202458,500 shares $279.63 thousand -13.7%N/A4.4 $4.78 1/15/202467,800 shares $323.41 thousand +1,132.7%N/A4.9 $4.77 12/31/20235,500 shares $22.99 thousand -11.3%N/A0.4 $4.18 12/15/20236,200 shares $26.10 thousand -39.2%N/A2.4 $4.21 11/30/202310,200 shares $42.84 thousand +117.0%N/A2.6 $4.20 11/15/20234,700 shares $20.77 thousand -4.1%N/A1 $4.42 10/31/20234,900 shares $17.30 thousand +2.1%N/A0.9 $3.53A new rule goes live in July — and the banks are quietly cashing in (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 10/15/20234,800 shares $20.88 thousand -34.3%N/A1 $4.35 9/30/20237,300 shares $30.22 thousand -73.1%N/A1.6 $4.14 9/15/202327,100 shares $123.58 thousand +173.7%N/A6 $4.56 8/31/20239,900 shares $59.30 thousand +135.7%N/A3.5 $5.99 8/15/20234,200 shares $24.82 thousand +23.5%N/A2.1 $5.91 7/31/20233,400 shares $20.35 thousand +21.4%N/A2.6 $5.99 7/15/20232,800 shares $18.31 thousand -46.2%N/A2.3 $6.54 6/30/20235,200 shares $32.34 thousand -3.7%N/A4 $6.22 6/15/20235,400 shares $35.75 thousand +54.3%N/A4.2 $6.62 5/31/20233,500 shares $22.47 thousand -31.4%N/A2.1 $6.42 5/15/20235,100 shares $33.76 thousand -42.7%N/A3.6 $6.62 4/30/20238,900 shares $58.65 thousand -60.4%N/A4.9 $6.59 4/15/202322,500 shares $146.93 thousand +9.2%N/A10.2 $6.53 3/31/202320,600 shares $124.38 thousand +32.1%N/A9.4 $6.04 3/15/202315,600 shares $91.42 thousand +2.6%N/A6.2 $5.86 2/28/202315,200 shares $95 thousand No ChangeN/A4.8 $6.25 2/15/202315,200 shares $97.58 thousand -2.6%N/A4.5 $6.42 1/31/202315,600 shares $100.62 thousand -1.3%N/A3 $6.45 1/15/202315,800 shares $107.48 thousand +22.5%N/A2.8 $6.80 12/30/202212,900 shares $84.50 thousand +10.3%N/A1.7 $6.55 12/15/202211,700 shares $80.03 thousand -14.0%N/A1.4 $6.84 11/30/202213,600 shares $87.04 thousand +9.7%N/A1.5 $6.40 11/15/202212,400 shares $86.06 thousand -2.4%N/A1.3 $6.94 10/31/202212,700 shares $79.12 thousand -7.3%N/A1.3 $6.23 10/15/202213,700 shares $83.43 thousand -12.7%N/A1.5 $6.09 9/30/202215,700 shares $105.03 thousand -20.7%N/A1.7 $6.69 9/15/202219,800 shares $124.94 thousand -26.4%N/A1.9 $6.31 8/31/202226,900 shares $157.63 thousand -9.4%N/A2 $5.86 8/15/202229,700 shares $201.66 thousand -34.3%N/A1.6 $6.79 7/31/202245,200 shares $279.79 thousand +5.6%N/A1.6 $6.19 7/15/202242,800 shares $270.50 thousand -3.4%N/A1.4 $6.32 6/30/202244,300 shares $300.35 thousand +13.3%N/A1.5 $6.78 6/15/202239,100 shares $265.49 thousand +141.4%N/A1.4 $6.79 5/31/202216,200 shares $123.12 thousand +76.1%N/A0.6 $7.60 5/15/20229,200 shares $63.48 thousand -47.4%N/A0.4 $6.90 4/30/202217,500 shares $140.88 thousand +14.4%N/A1.8 $8.05 4/15/202215,300 shares $292.23 thousand -26.8%N/A1.4 $19.10 3/31/202220,900 shares $429.50 thousand -54.5%N/A0.5 $20.55 3/15/202245,900 shares $941.41 thousand -26.7%N/A1 $20.51 2/28/202262,600 shares $1.51 million -19.4%N/A1.3 $24.15 2/15/202277,700 shares $2.05 million -5.0%N/A1.5 $26.37 1/31/202281,800 shares $2.24 million -40.3%N/A1.4 $27.35 1/15/2022137,000 shares $4.37 million +1,081.0%N/A2.4 $31.89 12/31/202111,600 shares $222.49 thousand -32.6%N/A0.4 $19.18 12/15/202117,200 shares $270.04 thousand +45.8%N/A0.6 $15.70 11/30/202111,800 shares $165.32 thousand -19.2%N/A0.5 $14.01 11/15/202114,600 shares $215.93 thousand +78.1%N/A0.7 $14.79 10/29/20218,200 shares $152.60 thousand -6.8%N/A0.4 $18.61 10/15/20218,800 shares $174.24 thousand -59.5%N/A0.4 $19.80 9/30/202121,700 shares $425.54 thousand +14.8%N/A0.9 $19.61A new rule goes live in July — and the banks are quietly cashing in (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 9/15/202118,900 shares $381.02 thousand -18.2%N/A0.6 $20.16 8/31/202123,100 shares $484.18 thousand +75.0%N/A0.3 $20.96 8/13/202113,200 shares $255.55 thousand No ChangeN/A0.1 $19.36 MOLN Short Interest - Frequently Asked Questions What is Molecular Partners' current short interest? Short interest is the volume of Molecular Partners shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 35,600 shares of MOLN short. 0.10% of Molecular Partners' shares are currently sold short. Learn More on Molecular Partners' current short interest. What is a good short interest ratio for Molecular Partners? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MOLN shares currently have a short interest ratio of 4.0. Learn More on Molecular Partners's short interest ratio. What is a good short interest percentage for Molecular Partners? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.10% of Molecular Partners' floating shares are currently sold short. Is Molecular Partners' short interest increasing or decreasing? Molecular Partners saw a decrease in short interest during the month of June. As of June 15th, there was short interest totaling 35,600 shares, a decrease of 10.6% from the previous total of 39,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Molecular Partners' float size? Molecular Partners currently has issued a total of 40,380,000 shares. Some of Molecular Partners' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Molecular Partners currently has a public float of 36,770,000 shares. How does Molecular Partners' short interest compare to its competitors? 0.10% of Molecular Partners' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Molecular Partners: Sage Therapeutics, Inc. (9.53%), Amylyx Pharmaceuticals, Inc. (6.19%), Maravai LifeSciences Holdings, Inc. (12.55%), Relay Therapeutics, Inc. (13.81%), Arvinas, Inc. (11.98%), Keros Therapeutics, Inc. (14.57%), Mind Medicine (MindMed) Inc. (15.20%), Ginkgo Bioworks Holdings, Inc. (29.65%), Cellectar Biosciences, Inc. (3.86%), Opthea Limited Unsponsored ADR (0.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Molecular Partners stock? Short selling MOLN is an investing strategy that aims to generate trading profit from Molecular Partners as its price is falling. MOLN shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Molecular Partners? A short squeeze for Molecular Partners occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MOLN, which in turn drives the price of the stock up even further. How often is Molecular Partners' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MOLN, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Sage Therapeutics Short Squeeze Amylyx Pharmaceuticals Short Squeeze Maravai LifeSciences Short Squeeze Relay Therapeutics Short Squeeze Arvinas Short Squeeze Keros Therapeutics Short Squeeze Mind Medicine (MindMed) Short Squeeze Ginkgo Bioworks Short Squeeze Cellectar Biosciences Short Squeeze Opthea Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MOLN) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Partners AG Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
